CNBC features a extraordinary interview about the benefits of the Exablate Neuro Treatment with Alexandra Lebenthal, Lebenthal Holdings president and CEO, and Dr. Michael Kaplitt, Weill Cornell Medicine department of neurological surgery vice-chairman for research.

For the full interview, CLICK HERE.